Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of hemoglobin in the treatment of cardiogenic shock

Use of hemoglobin in the treatment of cardiogenic shock

US Patent 6046161 · Granted Apr 4, 2000

Estimated economic value: $18,490,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of hemoglobin in the treatment of hypotension2000
Hemoglobin therapy in hemodialysis2000
Use of hemoglobin to treat septic shock2000
Use of hemoglobin in the treatment of stroke2000
Use of hemoglobin to treat systemic inflammatory response syndrome1999
Hemoglobin therapy in hemodialysis1999
Use of hemoglobin in the treatment of hemorrhagic shock1999
Administration of low dose hemoglobin to increase perfusion1997
Administration of low dose hemoglobin to increase perfusion1996
Administration of low dose hemoglobin to increase perfusion1994